Literature DB >> 9609741

Rhinovirus infection induces mucus hypersecretion.

A Yuta1, W J Doyle, E Gaumond, M Ali, L Tamarkin, J N Baraniuk, M Van Deusen, S Cohen, D P Skoner.   

Abstract

Rhinorrhea is a prominent symptom of the common cold. Although increases in vascular permeability and serous cell secretion have been demonstrated in human nasal mucus during active rhinovirus infections, changes in mucin constituents have not been quantified. Nonallergic (n = 48) and asymptomatic allergic rhinitis (n = 32) subjects were inoculated with rhinovirus type hanks before the spring allergy season. Nasal lavages were performed before inoculation (day 0), then daily for 5 days afterward. The subjects were divided into infected and noninfected groups on the basis of evidence of successful rhinovirus infection (nasal shedding of virus or fourfold increases in specific serum antibodies). Concentrations of interleukin (IL)-8, markers of vascular leak (IgG), seromucous cells (lysozyme), and mucoglycoprotein exocytosis [7F10-immunoreactive mucin (7F10-irm) and Alcian blue staining of acidic mucoglycoproteins] were measured in lavage fluids. The infected subgroup had maximal increases in nasal lavage fluid concentrations of IL-8 (sevenfold), IgG (fourfold), total protein (twofold), and gel-phase 7F10-irm (twofold) on day 3. There were no differences between infected allergic and nonallergic subjects. IL-8 and gel-phase 7F10-irm were significantly higher in infected than in noninfected subjects. In addition to promoting plasma exudation, rhinovirus hanks infection increases IL-8 and gel-phase mucin secretion. These processes may contribute to a progression from watery rhinorrhea to mucoid discharge, with mild neutrophilic infiltration during the common cold.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609741     DOI: 10.1152/ajplung.1998.274.6.L1017

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  Human nasal allergen provocation for determination of true allergic rhinitis: methods for clinicians.

Authors:  Ludmila I Litvyakova; James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

2.  Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures.

Authors:  Regina K Rowe; Andrew Pekosz
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

Review 4.  Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors:  Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 5.  Viral rhinitis.

Authors:  D A Gentile; D P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.806

Review 6.  Virus/Allergen Interaction in Asthma Exacerbation.

Authors:  James E Gern
Journal:  Ann Am Thorac Soc       Date:  2015-11

7.  Elastase- and LPS-exposed mice display altered responses to rhinovirus infection.

Authors:  Umadevi Sajjan; Shyamala Ganesan; Adam T Comstock; Jee Shim; Qiong Wang; Deepti R Nagarkar; Ying Zhao; Adam M Goldsmith; Joanne Sonstein; Marisa J Linn; Jeffrey L Curtis; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-11       Impact factor: 5.464

Review 8.  Rhinoviruses in the pathogenesis of asthma.

Authors:  Nikolaos G Papadopoulos; Stelios Psarras
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

9.  Lower respiratory tract infection induced by a genetically modified picornavirus in its natural murine host.

Authors:  Louis A Rosenthal; Renee J Szakaly; Svetlana P Amineva; Yina Xing; Marchel R Hill; Ann C Palmenberg; James E Gern; Ronald L Sorkness
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

Review 10.  Macrolide therapy in respiratory viral infections.

Authors:  Jin-Young Min; Yong Ju Jang
Journal:  Mediators Inflamm       Date:  2012-06-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.